Is Iovera Covered by Medicare? Coverage and Cost (2027)
Reviewed November 12, 2026. Iovera can be covered by Medicare, but coverage is not guaranteed. Original Medicare Part B may pay for iovera cryoneurolysis when your doctor documents that it is medically necessary and your regional Medicare contractor’s rules allow it, and some contractors now limit its use for long-term knee arthritis pain. If Part B covers it, you generally pay 20% of the Medicare-approved amount after the 2026 Part B deductible of $283.
Iovera (written “iovera°” by its maker) is a handheld device that uses extreme cold to temporarily block pain signals from a targeted nerve. Below we explain what Medicare looks at, the billing codes involved, what it can cost you, and how to check your own coverage before you book.
- Short answer: maybe. Medicare has no national coverage decision for iovera, so coverage depends on medical necessity, the code your provider bills, your Medicare Administrative Contractor’s (MAC’s) local rules and your plan.
- Part of Medicare: Part B (outpatient), or your Medicare Advantage plan if you have one.
- Knee arthritis limits: Noridian’s final policy for 2026 says cryotreatment around -88°C for knee pain is not reasonable and necessary outside the perioperative (around-surgery) setting.
- Your share in 2026: the $283 Part B deductible, then usually 20% coinsurance. 2027 Part B amounts have not been published yet.
- Medicare Advantage: your plan may require prior authorization.
What is iovera treatment?
Iovera is a cryoneurolysis device. A clinician places small needles through the skin next to a sensory nerve, and the needle tips freeze a small area of the nerve. That stops the nerve from sending pain signals for a period of time, and the nerve then recovers.
According to the FDA 510(k) clearance summary (K243677, December 2024), the iovera System is cleared to destroy tissue during surgery with freezing cold, to produce lesions in peripheral nerve tissue to block pain, and for “the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days.” The same document lists treatment temperatures of -55°C to -88°C. FDA clearance means the device can be sold for those uses. It does not mean Medicare must pay for it.
Doctors use iovera in two main ways: before knee replacement surgery to reduce pain after the operation, and for ongoing knee osteoarthritis pain in people who are not ready for, or not candidates for, surgery. That distinction matters for Medicare, as explained below. Pacira BioSciences developed iovera and in June 2026 announced an agreement to sell the iovera business to Zimmer Biomet.
Is iovera covered by Medicare? How coverage is decided
There is no national coverage determination (NCD) for cryoneurolysis. That leaves the decision to the MAC that processes claims in your state and to the facts in your medical record. Four things decide whether a claim is paid:
- Medical necessity. Your doctor has to document why the treatment is reasonable and necessary for your condition, for example your diagnosis, how long you have had pain and which treatments you have already tried.
- The code billed. Medicare contractors have told providers which codes to use for iovera (see the next section). A claim with the wrong code can be denied.
- Your MAC’s local coverage determination (LCD). Each MAC can publish its own rules. You can search them in the CMS Medicare Coverage Database.
- Your plan. Original Medicare follows the MAC’s rules. A Medicare Advantage plan must cover what Original Medicare covers, but it can require prior authorization and use its own network and copays.
Knee pain: what a recent Medicare policy says
Noridian, the MAC for Jurisdictions E and F (including California, Nevada, Hawaii, Arizona, Washington, Oregon and other Western states), finalized LCD L40265, Peripheral Nerve Injections and Procedures for Chronic Pain, for services on or after November 1, 2026. It allows genicular nerve ablation (radiofrequency or cryoneurolysis) for knee osteoarthritis only when strict criteria are met, including moderate to severe arthritis on X-ray, at least three months of pain despite conservative care, a successful diagnostic nerve block and documentation that you are a poor surgical candidate or decline surgery.
The same LCD states that “cryotreatment with temperatures around -88 degrees Celsius are not medically reasonable and necessary outside the perioperative setting.” Because iovera’s FDA documents list treatment temperatures up to -88°C, this may mean Medicare will not pay for iovera for chronic knee arthritis pain in Noridian states unless it is part of surgical care. Other MACs set their own rules, so ask your provider which LCD applies where you live.
Codes used to bill iovera
You do not need to know billing codes, but they explain why coverage varies. Two MACs have published billing articles for cryoneurolysis:
| Code | What it describes | Medicare status |
|---|---|---|
| 0441T | Cryoablation of a lower extremity nerve (temporary Category III code) | Code Noridian and Wellpoint Federal tell providers to use for iovera at the knee |
| 0440T / 0442T | Upper extremity nerve / nerve plexus or truncal nerve | Used for other body areas |
| 64624 / 64640 | Permanent nerve destruction | Both MACs say these are not appropriate for Medicare cryoneurolysis claims |
| C9809 | Cryoablation needle (e.g., iovera System) and disposable parts | Separate device payment in hospital outpatient departments and surgery centers for postsurgical pain, effective January 1, 2025 |
Sources: Noridian billing article A59752, Wellpoint Federal billing article A60507 and the CMS Non-Opioid Treatments for Pain Relief page. Both billing articles say the MAC may ask for records and review medical necessity case by case.
The non-opioid payment for surgery patients
Under Section 4135 of the Consolidated Appropriations Act, 2023 (often called the NOPAIN Act), CMS makes a temporary extra payment for qualifying non-opioid pain treatments used for postsurgical pain in hospital outpatient departments and ambulatory surgical centers, running through 2027. Iovera qualifies under HCPCS code C9809. CMS lists the current payment limit as $261.38 and a proposed limit of $368.12 in the CY 2027 proposed rule. This is the most Medicare pays the facility for the device itself. It is not your bill and not the total cost of treatment.
How much does iovera cost?
Neither CMS nor the manufacturer publishes a standard retail price for an iovera treatment, so we do not quote one. What you pay depends on:
- Whether Medicare covers it at all. If it is denied, you could owe the full charge. Your provider may ask you to sign an Advance Beneficiary Notice (ABN) first if they expect Medicare not to pay.
- Where it is done. A doctor’s office, hospital outpatient department and surgery center are paid differently, and facility fees can apply.
- Related services. Office visits, imaging guidance and a diagnostic nerve block can be billed separately.
- How many knees and sessions. Relief lasts up to 90 days per the FDA clearance, so some people need repeat treatments.
- Your coverage. Your deductible, coinsurance, any Medigap policy, or your Medicare Advantage copay.
Ask the provider for a written quote that lists each code. Then compare hospital outpatient and surgery center costs for related procedures with Medicare’s Procedure Price Lookup tool.
What you pay with Original Medicare (2026)
| Cost | 2026 amount |
|---|---|
| Part B monthly premium (standard) | $202.90 |
| Part B annual deductible | $283 |
| Coinsurance after the deductible | Usually 20% of the Medicare-approved amount |
| Yearly out-of-pocket cap | None in Original Medicare without supplemental coverage |
Figures from Medicare.gov. CMS has not yet released 2027 Part B amounts. See our guide to the 2026 Part B deductible for what counts toward it. A Medigap policy such as Plan G can pay the 20% coinsurance on covered services.
Medicare Advantage
Medicare.gov notes that with Medicare Advantage “you may need to get approval (prior authorization) from your plan before it covers certain services.” Call your plan before treatment, ask whether code 0441T needs prior authorization, and confirm the provider is in network. Plans also have a yearly out-of-pocket limit for covered services. If you are comparing plan types, see Medicare Advantage HMO vs. PPO.
How to check your coverage before treatment
- Ask your doctor whether iovera is for surgery-related pain or ongoing arthritis pain, and which codes they will bill.
- Ask whether your MAC’s LCD covers it for your diagnosis, and whether you meet the criteria.
- If you have Medicare Advantage, get prior authorization in writing.
- If you are asked to sign an ABN, read it. It means the provider expects Medicare may not pay and you could owe the bill.
- Ask about covered alternatives, such as knee gel injections or physical therapy.
Frequently asked questions
Does Medicare cover iovera treatment for knee pain?
Sometimes. Part B may cover it when it is medically necessary and billed correctly, but local rules differ. Noridian’s 2026 LCD treats cryotreatment around -88°C for knee pain as not reasonable and necessary outside the perioperative setting.
Is iovera covered before knee replacement surgery?
Surgery-related use is where Medicare support is clearest: CMS pays a separate device amount (code C9809) for postsurgical pain in hospital outpatient departments and surgery centers through 2027. Your own coverage still depends on medical necessity and your plan.
How much does iovera cost with Medicare?
If covered by Original Medicare, you pay the 2026 Part B deductible ($283) and then usually 20% of the approved amount. There is no official set price, so ask your provider for a quote.
How long does iovera last?
The FDA clearance describes relief of knee osteoarthritis pain and symptoms for up to 90 days. Results vary from person to person.
Does Medigap help pay for iovera?
Only if Original Medicare covers the service. Medigap pays its share of Medicare-approved costs, so it will not pay for a treatment Medicare denies.
Sources
- CMS Medicare Coverage Database: LCD L40265, Peripheral Nerve Injections and Procedures for Chronic Pain (Noridian)
- CMS Medicare Coverage Database: Billing and Coding, Cryoneurolysis Instructions (A59752, Noridian)
- CMS Medicare Coverage Database: Billing and Coding, Cryoneurolysis Instructions (A60507, Wellpoint Federal)
- CMS: Non-Opioid Treatments for Pain Relief
- FDA 510(k) summary K243677, iovera° System
- Medicare.gov: Medicare costs
- Medicare.gov: Compare Original Medicare and Medicare Advantage
- Medicare.gov: Procedure Price Lookup
- Pacira BioSciences: agreement to divest iovera business to Zimmer Biomet (June 30, 2026)
Disclaimer: The content in this article is provided for general informational purposes only. It may not be accurate, complete, or up-to-date and should not be relied upon as legal, financial, or other professional advice. Any actions or decisions taken based on this information are the sole responsibility of the user. Medicare-365 and/or BL Monahan Inc expressly disclaims any liability for any loss, damage, or harm that may result from reliance on this information. Please note that this article may contain affiliate endorsements and advertisements. The inclusion of such does not indicate an endorsement or approval of the products or services linked. Medicare-365 and/or BL Monahan Inc does not accept responsibility for the content, accuracy, or opinions expressed on any linked website. When you engage with these links and decide to make a purchase, we may receive a percentage of the sale. This affiliate commission does not influence the price you pay, and we disclaim any responsibility for the products or services you purchase through these links.